BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38368339)

  • 1. Implementing a pilot study of COVID-19 self-testing in high-risk populations and remote locations: results and lessons learnt.
    Marbán-Castro E; Getia V; Alkhazashvili M; Japaridze M; Jikia I; Erkosar B; Del Rey-Puech P; Martínez-Pérez GZ; Imnadze P; Gamkrelidze A; Denisiuk O; Reipold EI; Shilton S
    BMC Public Health; 2024 Feb; 24(1):511. PubMed ID: 38368339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation pilot study of community self-testing for COVID-19 among employees of manufacturing industries and their household members in 2022 to 2023.
    Chan HK; Marbán-Castro E; Rahman SA; Sem X; Zulkifli NF; Redzuan S; Aziz AA; Ayub N; Del Rey-Puech P; Reipold EI; Denisiuk O; Ahmad N; Warijo O; Abu Hassan MR; Shilton S
    PLOS Glob Public Health; 2024; 4(6):e0003269. PubMed ID: 38838031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 self-testing in Nigeria: Stakeholders' opinions and perspectives on its value for case detection.
    Undelikwo VA; Shilton S; Folayan MO; Alaba O; Reipold EI; Martínez-Pérez GZ
    PLoS One; 2023; 18(4):e0282570. PubMed ID: 37053243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-testing for SARS-CoV-2 in São Paulo, Brazil: results of a population-based values and attitudes survey.
    Martínez-Pérez GZ; Shilton S; Saruê M; Cesario H; Banerji A; Batheja D; Cunha JP; Baptista R; Schirmer J; Ivanova Reipold E; Machado Dias A
    BMC Infect Dis; 2022 Sep; 22(1):720. PubMed ID: 36056299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study.
    Blake H; Corner J; Cirelli C; Hassard J; Briggs L; Daly JM; Bennett M; Chappell JG; Fairclough L; McClure CP; Tarr A; Tighe P; Favier A; Irving W; Ball J
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33383781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing SARS-CoV-2 antigen testing scale-up in Rwanda: retrospective analysis of national programme data and qualitative findings.
    Rutayisire R; Boeke CE; Joseph J; Bansal N; Bigirimana N; Demke O; Kallarakal A; Karame P; Ndayishimiye R; Umumararungu E; Peter T; Khan S
    BMJ Open; 2023 Apr; 13(4):e066776. PubMed ID: 37185639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of COVID-19 Home Testing Through Community Health Centers: Results of the
    Nodora JN; Martinez ME; McDaniels-Davidson C; Shen J; Sitapati AM; Torriani F; Mandel J; Hill L
    J Prim Care Community Health; 2024; 15():21501319241259684. PubMed ID: 38864213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Values and preferences of the general population in Indonesia in relation to rapid COVID-19 antigen self-tests: A cross-sectional survey.
    Thomas C; Shilton S; Thomas C; Batheja D; Goel S; Mone Iye C; Ivanova E; Martínez-Pérez GZ
    Trop Med Int Health; 2022 May; 27(5):522-536. PubMed ID: 35332616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines).
    Hansen MA; Lekodeba NA; Chevalier JM; Ockhuisen T; Del Rey-Puech P; Marban-Castro E; Martínez-Pérez GZ; Shilton S; Radzi Abu Hassan M; Getia V; Weinert-Mizuschima C; Tenorio Bezerra MI; Chala L; Leong R; Peregino R; Keller S; Spruijt I; Johnson CC; Girdwood SJ; Nichols BE
    BMJ Open; 2024 Apr; 14(4):e078852. PubMed ID: 38631825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing COVID-19 testing strategies in K-12 schools in underserved populations: study protocol for a cluster-randomized trial.
    Hayes S; Malone S; Bonty B; Mueller N; Reyes SM; Reyes SA; Evans C; Wilcher-Roberts M; Watterson T; Akuse S; Shelley J; Yuan G; Lackey I; Prater J; Montgomery B; Williams C; Butler-Barnes ST; Harris K; Caburnay C; Dougherty NL; Liu J; Lai A; Neidich J; Fritz S; Newland JG
    BMC Public Health; 2022 Jun; 22(1):1177. PubMed ID: 35698094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.
    Ciccone EJ; Conserve DF; Dave G; Hornik CP; Kuhn ML; Herling JL; Song M; Alston S; Singler L; Schmidt MD; Jones A; Broderick S; Wruck LM; Kibbe WA; Aiello AE; Woods CW; Richmond A; Cohen-Wolkowiez M; Corbie-Smith G
    BMC Public Health; 2021 Dec; 21(1):2209. PubMed ID: 34863144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with regular testing of students for SARS-CoV-2 in primary and secondary schools: results from a cross-sectional study in two Norwegian counties, autumn 2021.
    Franconeri L; Stebbings S; Heradstveit P; Johansen M; Løken R; MacDonald E; Ødeskaug L; Naseer U
    BMC Public Health; 2023 Aug; 23(1):1548. PubMed ID: 37580682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 self-testing in Peru: a cross-sectional survey of values and attitudes of the general population.
    Martínez-Pérez GZ; Shilton S; Mallma Salazar PS; Pflucker Oses P; Torres-Slimming PA; Batheja D; Banerji A; Mallery A; Ivanova Reipold E; Carcamo C
    BMJ Open; 2023 Jul; 13(7):e068980. PubMed ID: 37407037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.